Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jerome T. Galea, Ph.D.

Co-Author

Back to Details
This page shows the publications co-authored by Jerome Galea and Leonid Lecca.
Jerome Galea
Connection Strength
2.834
Leonid Lecca
  1. A structured community engagement strategy to support uptake of TB active case-finding. Public Health Action. 2022 Mar 21; 12(1):18-23.
    View in: PubMed
    Score: 0.248
  2. A non-specialist depression care pathway for adolescents living with HIV and transitioning into adult care in Peru: a nested, proof of concept pilot study. Glob Ment Health (Camb). 2021; 8:e17.
    View in: PubMed
    Score: 0.235
  3. The Use of Wearable Technology to Objectively Measure Sleep Quality and Physical Activity Among Pregnant Women in Urban Lima, Peru: A Pilot Feasibility Study. Matern Child Health J. 2020 Jul; 24(7):823-828.
    View in: PubMed
    Score: 0.220
  4. Mental disorders and drug/alcohol use in patients commencing extensively drug-resistant tuberculosis treatment. Public Health Action. 2017 Sep 21; 7(3):237-239.
    View in: PubMed
    Score: 0.182
  5. Challenges in tuberculosis/HIV management in a country with a concentrated HIV epidemic. AIDS. 2017 06 01; 31(9):1207-1209.
    View in: PubMed
    Score: 0.178
  6. RAPID HOME-BASED HIV TESTING TO REDUCE COSTS IN A LARGE TUBERCULOSIS COHORT STUDY. Public Health Action. 2013 Jun 21; 3(2):172-174.
    View in: PubMed
    Score: 0.135
  7. A role for community-level socioeconomic indicators in targeting tuberculosis screening interventions. Sci Rep. 2022 01 17; 12(1):781.
    View in: PubMed
    Score: 0.061
  8. Prediction Tool to Identify Children at Highest Risk of Tuberculosis Disease Progression Among Those Exposed at Home. Open Forum Infect Dis. 2021 Nov; 8(11):ofab487.
    View in: PubMed
    Score: 0.061
  9. Identifying barriers and facilitators to implementation of community-based tuberculosis active case finding with mobile X-ray units in Lima, Peru: a RE-AIM evaluation. BMJ Open. 2021 07 07; 11(7):e050314.
    View in: PubMed
    Score: 0.059
  10. [Impact of SARS-CoV-2 pandemic on adolescents living with HIV in Lima, Peru]. Rev Peru Med Exp Salud Publica. 2021 Jan-Mar; 38(1):153-158.
    View in: PubMed
    Score: 0.059
  11. Closing delivery gaps in the treatment of tuberculosis infection: Lessons from implementation research in Peru. PLoS One. 2021; 16(2):e0247411.
    View in: PubMed
    Score: 0.058
  12. Incident Tuberculosis Diagnoses in Children at High Risk for Disease. Open Forum Infect Dis. 2021 Mar; 8(3):ofab075.
    View in: PubMed
    Score: 0.058
  13. Toward patient-centered tuberculosis preventive treatment: preferences for regimens and formulations in Lima, Peru. BMC Public Health. 2021 01 11; 21(1):121.
    View in: PubMed
    Score: 0.057
  14. Uncovering reasons for treatment initiation delays among children with TB in Lima, Peru. Int J Tuberc Lung Dis. 2020 12 01; 24(12):1254-1260.
    View in: PubMed
    Score: 0.057
  15. Two Clinical Prediction Tools to Improve Tuberculosis Contact Investigation. Clin Infect Dis. 2020 11 05; 71(8):e338-e350.
    View in: PubMed
    Score: 0.056
  16. Isoniazid Preventive Therapy in Contacts of Multidrug-Resistant Tuberculosis. Am J Respir Crit Care Med. 2020 10 15; 202(8):1159-1168.
    View in: PubMed
    Score: 0.056
  17. Tuberculosis clinical presentation and treatment outcomes in pregnancy: a prospective cohort study. BMC Infect Dis. 2020 Sep 18; 20(1):686.
    View in: PubMed
    Score: 0.056
  18. A positively selected FBN1 missense variant reduces height in Peruvian individuals. Nature. 2020 06; 582(7811):234-239.
    View in: PubMed
    Score: 0.055
  19. Mycobacterium tuberculosis Beijing Lineage and Risk for Tuberculosis in Child Household Contacts, Peru. Emerg Infect Dis. 2020 03; 26(3):568-578.
    View in: PubMed
    Score: 0.054
  20. Understanding health-related behavior among adolescents living with HIV in Lima, Peru. BMC Pediatr. 2019 10 31; 19(1):396.
    View in: PubMed
    Score: 0.053
  21. Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study. BMJ. 2019 10 24; 367:l5894.
    View in: PubMed
    Score: 0.053
  22. Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis. PLoS Med. 2019 09; 16(9):e1002907.
    View in: PubMed
    Score: 0.052
  23. Early progression to active tuberculosis is a highly heritable trait driven by 3q23 in Peruvians. Nat Commun. 2019 08 21; 10(1):3765.
    View in: PubMed
    Score: 0.052
  24. Whole genome sequencing identifies bacterial factors affecting transmission of multidrug-resistant tuberculosis in a high-prevalence setting. Sci Rep. 2019 04 03; 9(1):5602.
    View in: PubMed
    Score: 0.051
  25. Protective effects of household-based TB interventions are robust to neighbourhood-level variation in exposure risk in Lima, Peru: a model-based analysis. Int J Epidemiol. 2018 02 01; 47(1):185-192.
    View in: PubMed
    Score: 0.047
  26. Vitamin E Status Is Inversely Associated with Risk of Incident Tuberculosis Disease among Household Contacts. J Nutr. 2018 01 01; 148(1):56-62.
    View in: PubMed
    Score: 0.046
  27. Knowledge of tuberculosis and vaccine trial preparedness in Lima, Peru. Int J Tuberc Lung Dis. 2017 12 01; 21(12):1288-1293.
    View in: PubMed
    Score: 0.046
  28. Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru. Emerg Infect Dis. 2017 11; 23(11):1887-1890.
    View in: PubMed
    Score: 0.046
  29. Impact of Vitamin A and Carotenoids on the Risk of Tuberculosis Progression. Clin Infect Dis. 2017 Sep 15; 65(6):900-909.
    View in: PubMed
    Score: 0.045
  30. Prevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru. Int J Tuberc Lung Dis. 2017 08 01; 21(8):894-901.
    View in: PubMed
    Score: 0.045
  31. Erratum for Velásquez et al., Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis. Antimicrob Agents Chemother. 2017 Mar; 61(3).
    View in: PubMed
    Score: 0.044
  32. Nutritional Status and Tuberculosis Risk in Adult and Pediatric Household Contacts. PLoS One. 2016; 11(11):e0166333.
    View in: PubMed
    Score: 0.043
  33. Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis. Antimicrob Agents Chemother. 2016 11; 60(11):6766-6773.
    View in: PubMed
    Score: 0.043
  34. Acquired and Transmitted Multidrug Resistant Tuberculosis: The Role of Social Determinants. PLoS One. 2016; 11(1):e0146642.
    View in: PubMed
    Score: 0.040
  35. Identifying Hotspots of Multidrug-Resistant Tuberculosis Transmission Using Spatial and Molecular Genetic Data. J Infect Dis. 2016 Jan 15; 213(2):287-94.
    View in: PubMed
    Score: 0.039
  36. Cigarette smoking among tuberculosis patients increases risk of transmission to child contacts. Int J Tuberc Lung Dis. 2014 Nov; 18(11):1285-91.
    View in: PubMed
    Score: 0.037
  37. Age-specific risks of tuberculosis infection from household and community exposures and opportunities for interventions in a high-burden setting. Am J Epidemiol. 2014 Oct 15; 180(8):853-61.
    View in: PubMed
    Score: 0.037
  38. Bacillus Calmette-Guérin and isoniazid preventive therapy protect contacts of patients with tuberculosis. Am J Respir Crit Care Med. 2014 Apr 01; 189(7):853-9.
    View in: PubMed
    Score: 0.036
  39. The effect of HIV-related immunosuppression on the risk of tuberculosis transmission to household contacts. Clin Infect Dis. 2014 Mar; 58(6):765-74.
    View in: PubMed
    Score: 0.035
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.